The submitted policy aims to grant compounding pharmacies temporary authorization to produce and sell previously restricted peptides while permanent federal regulations undergo formal rulemaking.

From the articleTrump administration advances plan for peptide drugs favored by RFK Jr.Also in FDA advances peptide push to White House, Trump administration advances plan for peptide drugs favored by RFK Jr.